2005 AVAC Report: AIDS Vaccines at the Crossroads
We offer recommendations for the field in general, the Global HIV Vaccine Enterprise, policy makers, researchers and communities. Some of these recommendations will be familiar because we've made them before, and we reiterate them because we believe they are still needed and useful. (See our timeline of 10 years of AVAC recommendations for a perspective on progress over the past decade.) We also provide an update on tenofovir pre-exposure prophylaxis research.
And some analysis and recommendations are new. For example, we take an in-depth look at intellectual property issues and offer some "small step" recommendations that we believe will help move the field forward.
- For the Exec Summary PDF - English, fran?ais, espa?ol, ไทย
- For the full PDF
- For a list of recommendations in this Report PDF...
- For "The Past Year: Update, Analysis and Recommendations"
- For "Ten years and counting: A decade of AVAC recommendations"
- For "Get Enterprising: an open letter to the soon-to-be-named executive director of the Global HIV Vaccine Enterprise"
- For "Follow the money: Money, development and research"
- For a legislative update
- For "Intellectual property at the crossroads"
- For "Don't shoot the messenger: An update on tenofovir research"
- For "Advocates' work is never done"




